← Eichor
Condition: Macular Degeneration Intermediate Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Macular Degeneration Intermediate

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Efficacy and Safety Study of Ranibizumab 10mg/ml Injection (Incepta) in Patients With Diabetic Macular Edema
Phase 3 · 1 location(s) · Incepta Pharmaceuticals Ltd · NCT06305416QA108 Phase III Study in Subjects With Intermediate AMD
Phase 3 · 1 location(s) · Smilebiotek Zhuhai Limited · NCT07189169Personalised Monitoring of Early and Intermediate Age-related Macular Degeneration With Artificial Intelligence and Iden
Phase N/A · 7 location(s) · Medical University of Vienna · NCT06351670Subthreshold Laser Treatment for Reticular Pseudodrusen Secondary to Age-related Macular Degeneration
NA · 3 location(s) · Ospedale San Raffaele · NCT04847635Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD
Phase N/A · 1 location(s) · Maximilian Pfau · NCT07515521Dark Adaptation as an Early Indicator of Response to Statin Therapy for Intermediate AMD
Phase 2 · 1 location(s) · Massachusetts Eye and Ear Infirmary · NCT04735263A Clinical Trial Evaluating the Safety and Efficacy of a New Light Combination Therapy Addressing Intermediate AMD
NA · 1 location(s) · Oculox Technologies SA · NCT06557369Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
NA · 15 location(s) · i-Lumen Scientific AUS PTY LTD · NCT06662162
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.